New Cortex Study Uncovers How We Recognize What is True and What is False
Magnetic Resonance Imaging Reveals Two Distinct Processes
Milan, Italy, 17 June 2009 – A recent neuroimaging study reveals that the ability to distinguish true from false in our daily lives involves two distinct processes. Previous research relied heavily on the premise that true and false statements are both processed in the left inferior frontal cortex. Carried out by researchers from the Universities of Lisbon and Vita-Salute, Milan, the June Cortexstudy found that we use two separate processes to determine the subtle distinctions between true and false in our daily lives. Deciding whether a statement is true involves memory; determining one is false relies on reasoning and problem-solving processes.
The study examines the impact of true and false sentences on brain activity with a feature verification task and functional Magnetic Resonance Imaging (fMRI). Participants were asked to read simple sentences composed of a concept-feature pair (e.g. ‘the plane lands’) and to decide whether the sentence was true or false. Importantly, true and false statements were equated in terms of ambiguity, and exactly the same concepts and features were used across the two types of sentences. False statements differentially activated the right fronto-polar cortex in areas that have been previously related to reasoning tasks. The activations related to true statements involved the left inferior parietal cortex and the caudate nucleus bilaterally. The former activation may be hypothesized to reflect continued thematic semantic analysis and a more extended memory search. The caudate activation may also reflect this search and matching processes as well as the fact that recognizing a sentence as true is in itself a positive reward for the subject, as this area is also involved in processing reward-related information.
Considering the results from the present experiment and from previous studies, it is possible to reconcile the historically conflicting positions about language comprehension dating to Protagoras and Socrates. Paradoxically, it seems that when the differences between truth and falsehoods are clear-cut, we behave like relativists, and use similar processes to arrive at a decision. However, when differences are more subtle, (as in the Cortex study), we adhere to a categorical distinction and use qualitatively different processes to decide what is true from false.
Notes to Editors:
The article is “Neural differences in the processing of true and false sentences: Insights into the nature of “truth” in language comprehension” by J. Frederico Marques, Nicola Canessa and Stefano Cappa and appears in Cortex, Volume 45, Issue 6 (June 2009), published by Elsevier in Italy.
Full text of the article featured above is available to members of the media upon request. Please contact the Elsevier press office,email@example.com. To schedule an interview, contact Prof. Frederico Marques, firstname.lastname@example.org
Cortex is an international journal devoted to the study of cognition and of the relationship between the nervous system and mental processes, particularly as these are reflected in the behaviour of patients with acquired brain lesions, normal volunteers, children with typical and atypical development, and in the activation of brain regions and systems as recorded by functional neuroimaging techniques. It was founded in 1964 by Ennio De Renzi. The Editor in-chief of Cortex is Sergio Della Sala, Professor of Human Cognitive Neuroscience at the University of Edinburgh. Fax: 0131 6513230, e-mail: email@example.com. Cortex is available online at http://www.sciencedirect.com/science/journal/00109452
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).Media Contact